Dimensional Fund Advisors LP Zymeworks Inc. Transaction History

Dimensional Fund Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$27.35 - $37.28 $472,061 - $643,452	-17,260 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$26.5 - $38.23 $85,913 - $123,941	-3,242 Reduced 15.81%	17,260 $599,000
Q1 2021 May 14, 2021	SELL	$29.83 - $56.81 $72,665 - $138,389	-2,436 Reduced 10.62%	20,502 $647,000
Q4 2020 Feb 25, 2021	BUY	$39.12 - $54.99 $897,334 - $1.26 Million	22,938 New	22,938 $1.08 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $949M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.